EXCEDRIN (MIGRAINE RELIEF) Drug Patent Profile
✉ Email this page to a colleague
When do Excedrin (migraine Relief) patents expire, and when can generic versions of Excedrin (migraine Relief) launch?
Excedrin (migraine Relief) is a drug marketed by Haleon Us Holdings and is included in one NDA.
The generic ingredient in EXCEDRIN (MIGRAINE RELIEF) is acetaminophen; aspirin; caffeine. There are sixty-six drug master file entries for this compound. Forty-four suppliers are listed for this compound. Additional details are available on the acetaminophen; aspirin; caffeine profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for EXCEDRIN (MIGRAINE RELIEF)?
- What are the global sales for EXCEDRIN (MIGRAINE RELIEF)?
- What is Average Wholesale Price for EXCEDRIN (MIGRAINE RELIEF)?
Summary for EXCEDRIN (MIGRAINE RELIEF)
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Finished Product Suppliers / Packagers: | 4 |
Clinical Trials: | 1 |
Formulation / Manufacturing: | see details |
DailyMed Link: | EXCEDRIN (MIGRAINE RELIEF) at DailyMed |
![EXCEDRIN (MIGRAINE RELIEF) drug patent expirations Drug patent expirations by year for EXCEDRIN (MIGRAINE RELIEF)](/p/graph/s/t/EXCEDRIN_(MIGRAINE_RELIEF)-patent-expirations.png)
US Patents and Regulatory Information for EXCEDRIN (MIGRAINE RELIEF)
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Haleon Us Holdings | EXCEDRIN (MIGRAINE RELIEF) | acetaminophen; aspirin; caffeine | TABLET;ORAL | 020802-001 | Jan 14, 1998 | OTC | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for EXCEDRIN (MIGRAINE RELIEF)
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Haleon Us Holdings | EXCEDRIN (MIGRAINE RELIEF) | acetaminophen; aspirin; caffeine | TABLET;ORAL | 020802-001 | Jan 14, 1998 | ⤷ Sign Up | ⤷ Sign Up |
Haleon Us Holdings | EXCEDRIN (MIGRAINE RELIEF) | acetaminophen; aspirin; caffeine | TABLET;ORAL | 020802-001 | Jan 14, 1998 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for EXCEDRIN (MIGRAINE RELIEF)
See the table below for patents covering EXCEDRIN (MIGRAINE RELIEF) around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Japan | 2604599 | ⤷ Sign Up | |
Denmark | 0994714 | ⤷ Sign Up | |
World Intellectual Property Organization (WIPO) | 9903475 | ⤷ Sign Up | |
Canada | 2296492 | COMPOSITION D'ACETAMINOPHENE, D'ASPIRINE, ET DE CAFEINE ATTENUANT LA DOULEUR ET LES SYMPTOMES, DE LA MIGRAINE (USE OF COMPOSITIONS CONTAINING THE COMBINATION OF ACETAMINOPHEN, ASPIRIN AND CAFFEINE TO ALLEVIATE THE PAIN AND SYMPTOMS OF MIGRAINE) | ⤷ Sign Up |
Austria | 240105 | ⤷ Sign Up | |
>Country | >Patent Number | >Title | >Estimated Expiration |